Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1987
|
| gptkbp:ATCCode |
V03AB25
|
| gptkbp:CASNumber |
78755-81-4
|
| gptkbp:contraindication |
patients with benzodiazepine dependence
patients with seizure disorders |
| gptkbp:eliminationHalfLife |
40–80 minutes
|
| gptkbp:excretion |
gptkb:kidney
|
| gptkbp:genericName |
gptkb:flumazenil
|
| https://www.w3.org/2000/01/rdf-schema#label |
Romazicon
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Roche
|
| gptkbp:mechanismOfAction |
benzodiazepine receptor antagonist
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
nausea
vomiting seizures agitation |
| gptkbp:usedFor |
benzodiazepine overdose
|
| gptkbp:bfsParent |
gptkb:Flumazenil
gptkb:flumazenil |
| gptkbp:bfsLayer |
6
|